Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging
- PMID: 12350413
- DOI: 10.1016/s0720-048x(01)00468-5
Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging
Abstract
Objective: To investigate the usefulness of dynamic contrast magnetic resonance (MR) imaging in the differentiation of prostate cancer (PC) from benign prostate hypertrophy (BPH).
Materials and methods: Eleven PC patients and 13 BPH patients were entered into the analysis. The mean gradient (MG) was calculated from the T2* term-eliminated time-signal intensity curve obtained from dynamic contrast MR data, and the MG of PC and that of BPH were compared.
Results: The MG of PC was significantly higher than that of BPH. When the threshold value was set to 1.88% per s for discriminating PC from BPH, the sensitivity, specificity, and accuracy were 100, 85, and 92%, respectively.
Conclusion: The MG, which is derived from the T2* term-eliminated time-signal intensity curve, may be a useful index for differentiating PC from BPH.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
